Emergent Biosolutions
EBS
EBS
358 hedge funds and large institutions have $4.45B invested in Emergent Biosolutions in 2020 Q3 according to their latest regulatory filings, with 88 funds opening new positions, 110 increasing their positions, 138 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
358
Holders Change
+59
Holders Change %
+19.73%
% of All Funds
7.24%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.12%
New
88
Increased
110
Reduced
138
Closed
28
Calls
$11.4M
Puts
$7.26M
Net Calls
+$4.19M
Net Calls Change
+$1.61M
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
$528M |
| 2 |
State Street
Boston,
Massachusetts
|
$192M |
| 3 |
Renaissance Technologies
New York
|
$4.56M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$457M |
| 5 |
SCM
Snyder Capital Management
San Francisco,
California
|
$68.7M |
